Tag - SGLT2 inhibitors

  • Home
  • Tag -
  • SGLT2 inhibitors

Explore the ISN Global Trials Focus Selection for February and March, Featuring a “Trial of the Month” on the Efficacy and Safety of Aldosterone Synthase Inhibition 

ISN-ACT Global Trials Focus editorial team member Neeru Agarwal summarizes the design and outcomes of the latest ISN-ACT Global Trials Focus "Trial of the Month."  The "Trial of the Month" is available in several languages, now including German. Read all global trial selections from the ISN-ACT initiative here. In addition, selected clinical trials are demystified for the layperson.  Part of the...

April 23, 2024News, ResearchRead more...

ISN-Endorsed Events With ISN Participation in April – Apply for ISN Endorsement for Your Event!

The ISN endorses high-quality events within the kidney care community. Whether your event is big or small, if it addresses region-relevant topics, it could qualify for our endorsement. Apply for ISN endorsement for enhanced visibility, scientific merit, and educational impact. Discover all the benefits of ISN-endorsed meetings and how to apply here April 25-28, 2024               Jakarta,...

April 2, 2024ISN Participates, NewsRead more...

Beyond Blood Sugar: Ele Ferrannini on the Basis for the Transformative Power of SGLT2 Inhibitors for Kidney Disease Management at WCN’24

Ele Ferrannini, a professor of Internal Medicine at the University of Pisa and a senior research associate at the National Research Council Institute of Clinical Physiology, will present the plenary talk "Insights Into SGLT2 Inhibitors: A Story of Discovery" at WCN'24 in Hall A on Tuesday, April 16 at 11 a.m. Argentina time. Register for...

December 11, 2023News, WCNRead more...